Showing 321-330 of 1100 results for "".
eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORThe Resurgence of Ablative Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-resurgence-of-ablative-devices/18620/E. Victor Ross, MD, talks to host Joel L. Cohen, MD about the resurgence of traditional ablative devices. Dr. Ross says he never abandoned full-face CO2 resurfacing, but explains the key is to titrate the settings down—doing confluent 100 percent coverage but low-depth one pass on the forehead and cAsk An Expert: Establishing Yourself as an Expert
https://practicaldermatology.com/topics/practice-management/ask-an-expert-establishing-yourself-as-an-expert/18937/In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's expertise, becoming an educator, and finding a comfortable place working with industry, peers, and societies. Whether your interest is in cosmetic dermatology, acne, psoriasis, peDr. Joel Schlessinger's Tips for Hiring
https://practicaldermatology.com/topics/practice-management/dr-joel-schlessinger-39-s-tips-for-hiring/19295/In this video, Dr. Joel Schlessinger offers his advice for hiring employees. When finding new staff for his own practice, Dr. Joel Schlessinger makes sure each employee is a great fit for his organization. He puts each candidate through a test to find out if he or she is detail oriented, makes a poiExceeding Expectations: How One Device Transformed My Operations of Treating Acne and Rosacea
https://practicaldermatology.com/topics/general-topics/exceeding-expectations-how-one-device-transformed-my-operations-of-treating-acne-and-rosacea/20016/Dr. Jeffrey M. Weinberg is a dermatologist in Forest Hills, New York and is affiliated with multiple hospitals in the area, including Mount Sinai Hospital. With more than 20 years of practice, he is familiar with the various acne and rosacea treatments but found the Aerolase Neo Elite® to be the mosScientifically Speaking: New Directions in Acne Management, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-1/19939/The recognition that inflammation is at the heart of acne has led to changes in management approaches and better understanding of how treatments work. In the first of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD about acne approachesDermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-19-loans-taltz-for-peds-finacea-returns/19808/SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients aDermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecImproving Mastectomy Scars with the Vbeam Prima
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-mastectomy-scars-with-the-vbeam-prima/19692/Many women with breast cancer will undergo a mastectomy, resulting in major scarring on the breasts. Jill Waibel, MD is passionate about helping these women get the treatment they deserve post-surgery and uses the Vbeam Prima, a pulsed dye laser device, to help improve the appearance of the scars. W